Tone mix
Week by week 52 weeks
Share of Moderna, Inc. Common Stock's 1,456 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Sep 28, 2026 · tone -10Prediction: Moderna Stock Will Soar 100% by 2030-76
- Week of May 25, 2026 · tone -32Moderna Inc. (NASDAQ: MRNA) Stock Under Pressure as mRNA Platform Seeks New Applications-70
- Week of Mar 2, 2026 · tone +42Moderna Resolves Global Patent Litigation with Arbutus/Genevant+56
- Week of Nov 17, 2025 · tone +58Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates+50
- Week of Oct 19, 2026 · tone -22Moderna Named a Top Employer by Science for Twelfth Consecutive Year-49
- Week of Sep 7, 2026 · tone +23If You'd Invested in Moderna (MRNA) Stock 5 Years Ago, Here's How Much You'd Have Today (Hint: You'd Be Disappointed -- But Not If You Bought It 1 Year Ago.)-48
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Moderna, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 42 | +29 |
| Last 30 sessions | 174 | +12 |
| Last 90 sessions | 627 | +53 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
15 headlines, average tone +53: 9 positive, 5 neutral and 1 negative. The 8 most widely carried stories are listed; the table holds all 15.
- www.niagarafallsreview.ca · 8 outletsHealth Canada approves Moderna's mRNA flu and flu-COVID combo vaccinesPositive
- www.newjerseytelegraph.com · 4 outletsHealth Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 VaccinesPositive
- www.proactiveinvestors.com · 1 outletScottish Mortgage NAV total return rises 31.5% as SpaceX listing and Moderna trial success lift performancePositive
- www.thenews.com.pk · 1 outletModerna raises annual revenue forecast amid strong COVID vaccine demand overseasPositive
- www.aol.com · 1 outletModerna lifts annual revenue forecast on strong COVID vaccine demand overseasPositive
- markets.financialcontent.com · 1 outletFinancialContent - Moderna (NASDAQ:MRNA) delivers strong Q3 2026 numbers, stock soarsPositive
- seekingalpha.com · 1 outletModerna stock rises on Q3 beat, guidance hike (MRNA:NASDAQ)Positive
- www.sott.net · 1 outlet1.96 Million-Person Study Finds Pfizer COVID Shots Linked to 40% Higher All-Cause Mortality Compared to ModernaNegative
Show the table · 15 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Health Canada approves Moderna's mRNA flu and flu-COVID combo vaccines | www.niagarafallsreview.ca | 8 | Positive |
| Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines | www.newjerseytelegraph.com | 4 | Positive |
| Scottish Mortgage NAV total return rises 31.5% as SpaceX listing and Moderna trial success lift performance | www.proactiveinvestors.com | 1 | Positive |
| Moderna raises annual revenue forecast amid strong COVID vaccine demand overseas | www.thenews.com.pk | 1 | Positive |
| Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas | www.aol.com | 1 | Positive |
| FinancialContent - Moderna (NASDAQ:MRNA) delivers strong Q3 2026 numbers, stock soars | markets.financialcontent.com | 1 | Positive |
| Moderna stock rises on Q3 beat, guidance hike (MRNA:NASDAQ) | seekingalpha.com | 1 | Positive |
| 1.96 Million-Person Study Finds Pfizer COVID Shots Linked to 40% Higher All-Cause Mortality Compared to Moderna | www.sott.net | 1 | Negative |
| Moderna, Inc.: Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines | www.finanznachrichten.de | 1 | Positive |
| Health Canada approves Moderna's mRNA flu and flu-COVID combo vaccines - Medicine Hat NewsMedicine Hat News | medicinehatnews.com | 1 | Positive |
| Moderna Reports Third Quarter 2026 Financial Results and Provides Business Updates | www.tennesseedaily.com | 1 | Neutral |
| Moderna Reports Third Quarter 2026 Financial Results and Provides Business ... | www.pr-inside.com | 1 | Neutral |
| Moderna, Inc.: Moderna Reports Third Quarter 2026 Financial Results and Provides Business Updates | www.finanznachrichten.de | 1 | Neutral |
| Moderna (MRNA) earnings Q3 2026 | www.cnbc.com | 1 | Neutral |
| In Moderna Row, Fed. Circ. Mulls What's 'For The Government' | www.law360.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, November 5, 2026
9 headlines, average tone +31: 3 positive, 6 neutral and 0 negative. The 8 most widely carried stories are listed; the table holds all 9.
- www.hawaiitelegraph.com · 3 outletsModerna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual MeetingNeutral
- www.newjerseytelegraph.com · 2 outletsModerna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 StudyPositive
- www.aol.com · 2 outletsModerna, Humana and Elanco Earnings Previews: What Investors Should WatchNeutral
- www.finanznachrichten.de · 1 outletModerna, Inc.: Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 StudyPositive
- www.pr-inside.com · 1 outletModerna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward ...Positive
- seekingalpha.com · 1 outletModerna Earnings Preview: The Melanoma Breakthrough Is Real, But $221 Is Way Too MuchNeutral
- www.tickerreport.com · 1 outletModerna (MRNA) Projected to Announce Earnings on FridayNeutral
- www.finanznachrichten.de · 1 outletModerna, Inc.: Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual MeetingNeutral
Show the table · 9 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting | www.hawaiitelegraph.com | 3 | Neutral |
| Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study | www.newjerseytelegraph.com | 2 | Positive |
| Moderna, Humana and Elanco Earnings Previews: What Investors Should Watch | www.aol.com | 2 | Neutral |
| Moderna, Inc.: Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study | www.finanznachrichten.de | 1 | Positive |
| Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward ... | www.pr-inside.com | 1 | Positive |
| Moderna Earnings Preview: The Melanoma Breakthrough Is Real, But $221 Is Way Too Much | seekingalpha.com | 1 | Neutral |
| Moderna (MRNA) Projected to Announce Earnings on Friday | www.tickerreport.com | 1 | Neutral |
| Moderna, Inc.: Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting | www.finanznachrichten.de | 1 | Neutral |
| Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 ... | www.pr-inside.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
2 headlines, average tone +1: 1 positive, 0 neutral and 1 negative. Showing all 2.
- www.fool.com · 2 outletsModerna's Cancer Vaccine Is Incredibly Promising, but This Could Be a Major Obstacle to Its SuccessNegative
- www.esmmagazine.com · 1 outletModerna 2020, GDA Hone Italian Retail Logistics With ELEVAPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Moderna's Cancer Vaccine Is Incredibly Promising, but This Could Be a Major Obstacle to Its Success | www.fool.com | 2 | Negative |
| Moderna 2020, GDA Hone Italian Retail Logistics With ELEVA | www.esmmagazine.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
4 headlines, average tone +49: 2 positive, 2 neutral and 0 negative. Showing all 4.
- www.fool.com · 3 outletsIf Moderna's CEO Is Right, the Stock's Rally Could Just Be Getting StartedPositive
- www.fool.com · 1 outletCould Investing in Moderna's Stock Double Your Money?Positive
- www.themarketsdaily.com · 1 outlet120,480 Shares in Moderna, Inc. $MRNA Purchased by Mirae Asset Global Investments Co. Ltd.Neutral
- www.themarketsdaily.com · 1 outletAnalyzing Insmed (NASDAQ:INSM) and Moderna (NASDAQ:MRNA)Neutral
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| If Moderna's CEO Is Right, the Stock's Rally Could Just Be Getting Started | www.fool.com | 3 | Positive |
| Could Investing in Moderna's Stock Double Your Money? | www.fool.com | 1 | Positive |
| 120,480 Shares in Moderna, Inc. $MRNA Purchased by Mirae Asset Global Investments Co. Ltd. | www.themarketsdaily.com | 1 | Neutral |
| Analyzing Insmed (NASDAQ:INSM) and Moderna (NASDAQ:MRNA) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, November 2, 2026
7 headlines, average tone -14: 1 positive, 4 neutral and 2 negative. Showing all 7.
- www.fool.com · 2 outletsStock Split Watch: Is Moderna Next? | The Motley FoolNeutral
- seekingalpha.com · 1 outletNotable analyst calls this week: Broadcom, Moderna and Abbott among top picks (SP500:) (AVGO:NASDAQ)Positive
- baystreet.ca · 1 outletBaystreet.ca - SK Hynix Shares Fell, Moderna Slumped, and Bond Yields DroppedNegative
- 247wallst.com · 1 outletRegeneron Surges 12% as Sanofi Dupixent Windfall and Eylea HD Power Earnings Beat; Moderna Slides 2%, Merck Edges Higher, Pfizer Ticks UpNegative
- www.tickerreport.com · 1 outlet3,233 Shares of Moderna, Inc. $MRNA Bought by Pinkerton Wealth LLCNeutral
- www.aol.com · 1 outletStock Split Watch: Is Moderna Next?Neutral
- www.tickerreport.com · 1 outletModerna, Inc. $MRNA Stock Holdings Raised by VIRGINIA RETIREMENT SYSTEMS ET AlNeutral
Show the table · 7 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Stock Split Watch: Is Moderna Next? | The Motley Fool | www.fool.com | 2 | Neutral |
| Notable analyst calls this week: Broadcom, Moderna and Abbott among top picks (SP500:) (AVGO:NASDAQ) | seekingalpha.com | 1 | Positive |
| Baystreet.ca - SK Hynix Shares Fell, Moderna Slumped, and Bond Yields Dropped | baystreet.ca | 1 | Negative |
| Regeneron Surges 12% as Sanofi Dupixent Windfall and Eylea HD Power Earnings Beat; Moderna Slides 2%, Merck Edges Higher, Pfizer Ticks Up | 247wallst.com | 1 | Negative |
| 3,233 Shares of Moderna, Inc. $MRNA Bought by Pinkerton Wealth LLC | www.tickerreport.com | 1 | Neutral |
| Stock Split Watch: Is Moderna Next? | www.aol.com | 1 | Neutral |
| Moderna, Inc. $MRNA Stock Holdings Raised by VIRGINIA RETIREMENT SYSTEMS ET Al | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Moderna, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.